Genocea Biosciences, Inc. (GNCA) Social Stream



Genocea Biosciences, Inc. (GNCA): $0.00

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add GNCA to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#300 of 500

in industry

GENOCEA BIOSCIENCES INC (GNCA) Price Targets From Analysts

Use the tables below to see what analysts covering GENOCEA BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-28 3 $9 $4.5 $6.375 $0.062 10182.26%
2022-03-10 3 $9 $4.5 $6.5 $0.062 10383.87%
2022-04-11 3 $9 $4.7 $6.566 $0.062 10490.32%
2022-04-12 3 $9 $3 $5.675 $0.062 9053.23%
2022-04-27 3 $9 $3 $5.425 $0.062 8650%
2022-04-28 2 $3 $0.16 $1.58 $0.062 2448.39%

The Trend in the Analyst Price Target


Over the past 25 months, GNCA's average price target has gone down $13.28.

GNCA reports an average of 368.46% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-05 3 8 4.40 6.100 2.000 205%
2022-04-11 3 9 4.70 6.566 0.600 994.33%
2022-04-12 3 9 3.00 5.675 0.490 1058.16%
2022-04-27 3 9 3.00 5.425 0.410 1223.17%
2022-04-28 3 5 0.16 2.720 0.408 566.67%

GNCA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 2 0 0 2

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • GENOCEA BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 699.53% of all US stocks.
  • GENOCEA BIOSCIENCES INC's average analyst price target is greater than 22.68% of all US stocks.
  • In the context of Healthcare stocks, GENOCEA BIOSCIENCES INC's number of analysts covering the stock is higher than 74.83% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, GENOCEA BIOSCIENCES INC's variance in analysts' estimates is lower than -504.93% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GENOCEA BIOSCIENCES INC are GMDA, GLUE, and FUSN.

Is GNCA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!